Canada Life has unveiled a range of technology developments to be released over the next six weeks.
The National Institute for Health and Clinical Excellence (Nice) has rejected the use of Avastin for metastatic breast cancer on the NHS.
Resolution, the buy-out vehicle launched by entrepreneur Clive Cowdery, is highly unlikely to make any further acquisitions and will instead focus on developing new life products.
LifeSearch has revealed it arranged £4bn worth of cover and saw a 10% increase in the number of under 35-year-olds who took out protection products last year.
Three-quarters of over-50s expect the government to pay for all or most of their long-term care needs, research suggests.
Ageas Protect has added a new national sales manager and strategic account manager to join its protection business from Bupa.
Morgan Ash has launched a Supplementary Tele-Interview service, designed to allow underwriters who need further evidence on a case to obtain it quickly in a secure manner.
The asset threshold over which individuals cannot access state help with long term care (LTC) bills has been frozen at £23,250 until 2013.
Groupama Healthcare saw its business grow, as total revenues at Groupama Insurances rose 4.6% to £470.9 million (2009: £450.3 million), mainly down to rising premium rates in the company's private car portfolio.
The Government has announced an independent review into sickness absence in the workplace.